Neuro-pharmacology Flashcards
Phenytoin
For simple partial and complex partial1st line for tonic clonic1st line prophylaxis for status epilepticusMechanism: Increase Na+ channel inactivationNotes: Fosphenytoin for parenteral use
Carbamazepine
For both simple and complex partial.1st line for tonic-clonicMechanims: increases Na+ channel inactivationNotes: 1st line for trigeminal neuralgia
Lamotrigine
For both Simple and complex partial.Used in Tonic clonic.Blocks voltage-gated Na+ channel.
Gabapentin
For both simple and complex partialTonic clonicDesigned as GABA analog, but primarily inhibits HVA Ca2+ channelsNotes: Also used for peripheral neuropathy; bipolar disorder
Topiramate
For simple and complex partialFor tonic-clonicMechanism: Blocks Na+ channels and increases GABA action
Phenobarbital
For simple and complex partial For Tonic-clonicIncreases GABA action1st line in CHILDREN AND PREGNANT WOMEN
Valproic acid
For simple and complex partial1st line for tonic-clonic generalizedUseful for AbsenceIncrease Na+ channel inactivation and increases GABA concentrationUsed for myoclonic seizures
Ethusuximide
2st line for Absence seizuresBlocks thalamic T-type Ca2+ channels
Benzodiazepines (diazepam or lorazepam)
1st line for acute status epilepticusIncreases GABAa actionAlso used for seizures of eclampsia, though first line is MgSO4
Tiagabine
For simple and complex partial.Inhibits GABA uptake
Vigabatrin
For simple and complex partial.Irreversibly inhibits GABA transaminase - increases GABA
Levetiracetam
For simple and complex partial.For generalized tonic-clonic.Unknown mechanism - may modulate GABA and glutamate release
What are the 1st line therapies for tonic-clonic
Phenytoin, Carbamazepine, and valproic acid
Benzodiazepines toxicities
Sedation, tolerance, dependenceAlprazolam, Triazolam, Oxazepam, Midazolam (ATOM) (short-acting): high risk of dependence/withdrawalLorazepam, Estazolam, Temazepam (LET) (medium-acting): moderately severe side effectsDrazepam, Flurazepam, Clorazepate, Chlordiazepoxide (DFCC) (long-acting): daytime drowsiness/falls
Carbamazepine toxicity
Diplopia, ataxia, blood dyscrasias (agranulocytosis, aplastic anemia), liver toxicity, teratogenesis, induction of cytochrome P-450 system, SIADH, Stevens-Johnson syndrome
Ethosuximide toxicity
GI distress, fatigue, headache, urticaria, Stevens-Johnson syndromeEFGH - ehtosuximide, fatigue, GI, headache
Phenytoin toxicity
Nystagmus, diplopia, ataxia, sedation, gingival hyperplasia, hirsutism, megaloblastic anemia, teratogenesis *fetal hydantoin syndrome), SLE-like syndrome, induction of cytochrome P-450
Valproic acid toxicity
GI distress, rare but fatal hepatotoxicity (measure LFTs), neural tube defects in fetus (spina bifida), tremor, weight gain. Contraindicated in pregnancy.
Lamotrigine toxicity
Steven-Johnson syndrome
Gabapentin toxicity
Sedation, ataxia
Topiramate toxicity
SEdation, mental dulling, kidney stones, weight loss
Phenytoin: mechanism, clinical use, toxicity
Mechanism: Use-dependent block of Na+ channels; increases refractory period; inhibition of glutamate release from excitatory presynaptic neuron.Clinical use: Tonic-clonic seizures. Also a class IB antiarrhythmic.Toxicity: Nystagmus, ataxia, diplopia, sedation, SLE-like syndrome, induction of cytochrome P-450. Chronic use produces gingival hyperplasia in children, peripheral neuropathy, hirsutism, megaloblastic anemia (decreased folate absrption). Teratogenic (fetal hydantoin syndrome)
Barbituates (phenobarbital, pentobarbital, thiopental, secobarbital) are contraindicated in?
porphyria
Barbiturates (phenobarbital, pentobarbital, thiopental, secobarbital) Mechanism, Clinical use, toxicity
Mechanism: Facilitate GABAa action by increasing the duration of Cl- channel opening, thus decreasing neuron firing.Clinical use: sedative for anxiety, seizures, insomnia, induction of anesthesia (thiopental)Toxicity: Dependence, additive CNS depression effects with alcohol, respiratory or cardiovascular depression (can lead to death), drug interactions owing to induction of liver microsomal enzymes (cytochrome p-450).Treat overdose with symptom management (assist repiration, increase BP), induces enzymes involved in heme synthesis –> acute intermittant porphyria exacerbation.
Benzodiazepines
Diazepam, lorazepam, triazolam, temazepam, oxazepam, midazolam, chlordiazepoxide, alprazolam
Short acting benzodiazepines.
TOM: Triazolam, oxazepam, midazolam.Highest addictive potential
Mechanism of benzodiazepines (diazepam, lorazepam, triazolam, temazepam, oxazepam, midazolam, chlordiazepoxide, alprazolam)
Facilitate GABAa action by increased frequency of Cl- channel opening. Decreased REM sleep.Most have long half-lives and active metabolites.
Clinical use of benzodiazepines (diazepam, lorazepam, triazolam, temazepam, oxazepam, midazolam, chlordiazepoxide, alprazolam)
Anxiety, spasticity, status epilepticus (lorazepam and diazepam), detoxification (especially alcohol withdrawal - DTs), night terrors, sleepwalking, general anesthetic (amnes, muscle relaxation), hypnotic (insomnia)
Benzos, Barbs, and EtOh all bind to?
GABA(A)-R, which is a ligand-gated chloride channel (increase frequency of channel opening)
Toxicity of benzodiazepines
Dependence, additive CNS depression effects with alcohol.less risk of respiratory depression and coma than with barbituates.Treat overdose with flumazenil (competitive antagonist at GABA benzodiazepine receptor)
Nonbenzodiazepine hypnotics
Zolpidem (ambien), zaleplon, eszopiclone
Mechanism, clinical use, and toxicities of nonbenzodiazepine hyponotics (Zolpidem (ambien), zaleplon, eszopiclone)
Mechanism: Act via BZ1 receptor subtype and is reversed by flumazenilClinical use: insomniaToxicity: Ataxia, headaches, confusion. short duration because of rapid metabolism by liver enzymes.Unlike older sedative-hypnotics, cause only modest day-after psychomotor depression and few amnestic effects.Lower dependence risk than benzodiazepines.
Inhaled anesthetics
halothane, enflurane, isoflurane, sevoflurane, methoxyflurane, nitrous oxide
Inhaled anesthetics (halothane, enflurane, isoflurane, sevoflurane, methoxyflurane, nitrous oxide) effects, toxicity
mechanism is unknown. (HST150: Isoflurane potentiates GABAa, whereas nitrous oxide xenon, and cyclopropane do not.)Effects: Myocardial depression, respiratory depression, nausea/emesis, increases cerebral blood flow and decreases cerebral metabolic demandToxicity: hepatotoxicity (halothane), nephrotoxicity (methoxyflurane), proconvulsant (enflurane), malignant hyperthermia (rare), expansion of trapped gas (NO)
Which inhaled anesthetic is hepatotoxic?
halothane
Which inhaled anesthetic is nephrotoxic?
methoxyflurane
Which inhaled anesthetic is a proconvulsant?
enflurne
Intravenous anesthetics - Barbiturates
Thiopental - high potency (because lipid solubility), high lipid solubility, rapid entry into brain.Used for induction of anesthesia and short surgical procedures.Effect terminated by rapid redistribution into tissue and fat.Decreased cerebral blood flow.
intravenous anesthetics - benzodiazepines
Midazolam most common drugs used for endoscopy; used adjunctively with gaseous anesthetics and narcotics.May cause severe postoperative respiratory depression, decreased BP (treat overdose with flumazenil), and amnesia.
Intravenous anesthetics - Arlcyclohexylamines
Ketamine - PCP analogs that act as dissociative anesthetics.Block NMDA receptors.Cardiovascular stimulants. Cause disorientation, hallucination, and bd dreams.Increased cerebral blood flow.
Intravenous anesthetics - opiates
Morphine, fentanyl used with other CNS depressants during general anesthesia
Intravenous anesthetics - Propofol
Used for rapid anesthesia induction and short procedures.Less postoperative nausea than thiopental. Potentiates GABAa.
Local anesthetics: esters and amides
Esters - procaine, cocaine, tetracaine.Amides (two I’s) = lidocaine, mepivacaine, bupivacaine
Mechanism of local anesthetics - procaine, benzocaine, cocaine, tetracaine, lidocaine, mepivacaine, bupivacaine
Block Na+ channels by binding to specific receptors on inner portion of channel.Preferentially bind to activated Na+ channels, so most effective in rapidly firing neurons.Tertiary amine local anesthetics penetrate membrane in uncharged form, then bind to ion channels as charged form.Often norepinephrine is coinjected in order to prolong time to removal from circulation. This has its own problems, as NE is packaged in neurotoxant antioxidants and at a low pH, which impairs anesthetic penetration (many local anesthetics are bases).Sensations from more proximal regions are blocked earlier and recover later than those from more distal segments. This reflects the diffusion of anesthetic through the somatotopically organized peripheral nerve.
Local anesthetics - procaine, cocaine, tetracaine, lidocaine, mepivacaine, bupivacaine principles
Principles:1) In infected (acidic tissue), alkaline anesthetics are charged and cannot penetrate membrane effectively.More anesthetic needed.2) Order of nerve blockade: small-diameter fibers>large diameter. Myelinated fibers> unmyelinated.Overall, size factor predominates over myelination such that small myelinated fibers > small unmyelinated fibers>large myelinated fibers>large unmyelinated fibers. Order of loss - pain (lost first), > temperature > touch > pressure (lose last)3. Except for cocaine, given with vasoconstrictors (usually epinephrine) to enhance local action (decreases bleeding, increases anesthesia by decreased systemic concentration)
Local anesthetics - procaine, cocaine, tetracaine, lidocaine, mepivacaine, bupivacaine clinical use and toxicities
Clinical use: minor surgical procedures, spinal anesthesia.if allergic to esters, give amides.Toxicity: CNS excitation, severe cardiovascular toxicity (bupivacaine), hypertension, hypotension, and arrhythmias (cocaine)
Neuromuscular blocking drugs- use
Used for muscle paralysis in surgery or mechanical ventilation.Selective for motor (vs. autonomic) nicotinic receptor
Neuromuscular drugs - depolarizing
Succinylcholine (complications include hypercalcemia and hyperkalemia). Reversal of blockade:Phase I (prolonged depolarization) - no antidote.Block potentiated by cholinesterase inhibitors.Phase II (repolarized but blocked) - antidote consists of cholinesterase inhibitors (e.g. neostigmine)
Neuromuscular blocking drugs-nondepolarizing
Tubocurarine, atracurium, mivacurium, pancuronium, vecuronium, rocuroniumCompetitive blockage - compete with nicotonic Ach for receptors (nAChRs). Reversal of blockage - neostigmine, edrophonium, and other cholinesterase inhibitors
Depolarizing effects - organophosphate - inhibit AchE.Treatment?
Common cause of poisoning - treat with atropine, pralidoxime
Dantrolene
Used in the treatment of malignant hyperthermia, which is caused by inhalation anesthetics (except nitric oxide) and succinylcholine.Also used to treat neuroleptic malignant syndrome (a toxicity of antipsychotic drugs).Mechanism: prevents the release of Ca2+ from the sarcoplasmic reticulum of skeletal muscle
Dopamine receptor agonists for Parkinson’s
Bromocriptine, pramipexole, ropinirole (non-ergot); non-ergots are preferred
Drugs for increasing dopamine in Parkinson’s
Amantadine (may incrase dopamine relase); also used as an antiviral against influenza A and rubella.Toxicity = ataxiaLevo-dopa with carbidopa (converted to dopamine in CNS. Carbidopa inhibits peripheral conversion to dopamine)
Drugs for parkinson’s: preventing dopamine breakdown
Selegiline (selective MAO type B inhibitor); entacapone, tolcapone *COMT inhibitors - prevents L-dopa degradation, thereby increasing dopamine availability)
Parkinson’s drugs: curb excess cholinergic activity
Benztropine (antimuscarinic; improves tremor and rigidity but has little effect on bradykinesia)
How to treat essential or familial tremors?
Beta-blocker (e.g. propranolol)
L-dopa can cross the blood-brain barrier and is changed into dopamine by?
dopa decarboxylasecarbidopa keeps this from happening peripherally
Toxicity of Levodopa
Arrhythmias from peripheral conversion to dopamine.Long-term use can lead to dyskinesia following administration, akinesia between doses.Carbidopa, a peripheral decarboxylase inhibitor, is giving with L-dopa to increase bioavailbility of L-dopa in the brain and decrease peripheral effects
Selegiline - Mechanism, Clinical use, toxicity
Mechanism: Selectively inhibits MAO-B, which preferentially metabolizes dopamine over NE and 5-HT, thereby increasing the availability of dopamine.Clinical use: Adjunctive agent to L-dopa in treatment of Parkinson’s diseaseToxicity: May enhance effects of L-dopa
Alzheimer’s drugs
MemantineMechanism - NMDA receptor antagonist; helps prevent excitotoxicity (mediated by Ca2+)Toxicity - Dizziness, confusion, hallucinationsDonepezil, galantamine, rivastigmineMechanism: Acetylcholinesterase inhibitorsToxicity: Nausea, dizziness, insomnia
Huntington’s drugs
Disease: Increase dopamine, decreased GABA + AChReserpine + tetrabenazine = amine depletingHaloperidol = dopamine receptor antagonist
Sumatriptan
Mechanism: 5-HT agonist.Causes vasoconstriction, inhibition of trigeminal activation and vasoactive peptide release.Half-life < 2 hours. Clinical use: Acute migraine, cluster headache attacksToxicity: Coronary vasospasm (contraindicated in patients with CAD or Prinzmetal’s angina), mild tingling
Treatment for ADHD
methylphenidate (Ritalin), amphetamines (Dexedrine), atomoxetine (nonstimulate SNRI)
Treatment for Tourette’s syndrome
antipsychotics (e.g., haloperidol)
Treatment for bipolar disorder
Lithium, valproic acid, carbamazepine, atypical antipsychotics (use of antidepressants lead to increased mania)
Depressants - Intoxication and withdrawal
Intoxication - nonspecific: mood elevation, decreased anxiety, sedation, behavioral disinhibition, respiratory depressionWithdrawal - nonspecific: anxiety, tremor, seizures, insomnia
Alcohol (depressant)
Intoxication: Emotional lability, slurred speech, ataxia, coma, blackouts. Serum gamma-glutamyltransferase (GGT) - sensitive indiator of alcohol use.Lab AST is twice ALT value.Treatment: NaltrexoneWithdrawal: Symptoms similar to other depressants.Severe alcohol withdrawal: Delerium tremens- delirium, tremors, autonomic instability.Treatment: Benzodiazepines
Opioids (e.g. morphine, heroin, methadone) (depressant)
Intoxication: CNS depression, nausea, vomiting, constipation, pupillary constriction (pinpoint pupils), seizures (overdose is life-threatening).Treatment: Naloxone, naltrexoneWithdrawal: Sweating, dilated pupils, piloerection (cold turkey), fever, rhinorrhea, nausea, stomach cramps, diarrhea (fluelike symptoms). Treat symptomatically
Barbiturates (depressant)
Intoxication: Low safety margin, marked respiratory depression. Treatment: symptom management (assist respiration, increase BP)Withdrawal: Delirium, life-threatening cardiovascular collapse
Benzodiazepines (depressant)
Intoxication:Greater safety margine. Ataxia, minor respiratory depression.Treatment: Flumazenil (competitive GABA antagonist)
Stimulants: Intoxication and withdrawal
Intoxication: Nonspecific: mood elevation, psychomotor agitation, insomnia, cardiac arrythmias, tachycardia, anxietyWithdrawal: Nonspecific: post-use “crash”, including depression, lethargy, weight gain, headache
Amphetamines (stimulants)
Intoxication: Impaired judgment, pupillary dilation, prolonged wakefulness and attention, delusions, hallucinations, fever Withdrawal: Stomach cramps, hunger, hypersomnolence
Cocaine (stimulant)
Intoxication: Impaired judgment, pupillary dilationf, hallucinations (including tactile), paranoid ideations, angina, sudden cardiac death.Treatment: benzodiazepines.Withdrawal: Suicidality, hypersomnolence, malaise, severe psychological craving
Caffeine (stimulants)
Intoxication: Restlessness, increased diuresis, muscle twitching
Nicotine (stimulant)
Intoxication: RestlessnessWithdrawal: irritability, anxiety, craving.Treatment: nicotine patch, gum, lozenges.Bupropion/varenicline
PCP (Hallucinogen)
Intoxication: Belligerence, impulsiveness, fever, psychomotor agitation, vertical and horizontal nystagmus, tachycardia, homicidality, psychosis, deliriumWithdrawal: Depression, anxiety, irritability, restlessness, anergia, disturbances of thought and sleep
LSD (hallucinogens)
Intoxication: Marked anxiety or depression, delusions, visual hallucinations, flashbacks, pupillary dilation
Marijuana (hallucinogen)
Intoxication: Euphoria, anxiety, paranoid delusions, perception of slowed time, impaired judgment, social withdrawal, increased appetite, dry mouth, hallucinationsWithdrawal: Irritability, depression, insomnia, nausea, anorexia.Most symptoms peak in 48 hours and last for 5-7 days.Can detected in urine for up to 1 month after use.
Heroin addiction
Users at increased risk for hepatitis, abscesses, overdose, hemorrhoids, AIDS, and right-sided endocarditis.Look for track marks (needlesticks in veins). Methadone - long-acting oral opiate; used for heroin detoxification or long-term maintenance (prevent withdrawal symptoms)Suboxone - naloxone + buprenorphine (partial agonist); long acting with fewer withdrawal symptoms than methaodone. naloxone is inactive when administered orally, but will induce withdrawal when injected.Pentazocine - partial agonist; can parcipitate withdrawal
What is given to condition patients not to abuse alcohol
disulfiram